Beta · prototype— This site is under construction: rankings, texts and features change every week.

Basecamp Research

Active#10 worldwide · AI drug discovery

AI drug discovery

HQUnited Kingdom
Last roundSeries C · Sep 2026

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
AI drug discovery · worldwideTop 13#10Edition 0 (beta) · Sep 202621 Nov 2026
Rank historySep 2026 · #10 AI drug discoveryFirst edition: no movements yet.

Estimated valuation

AI · AI drug discovery ranking (worldwide)
≈ USD 700MUSD 350M–1.4bn · Hundreds of M$ Low confidence
Anchor
Last known equity round: Series C · USD 140M · Sep 2026

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestorsSource
Sep 2026Series CUSD 140MEquityS32, Nvidia, Anthology Fundsiliconangle.com

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Basecamp Research as a PDF, on one of three angles only:

ValuationWhat is Basecamp Research worth?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Comparable companies in ai drug discovery

Full ai drug discovery ranking →

Investors in Basecamp Research: S32 · NVIDIA · Anthology Fund

Sources. siliconangle.com

Last updated: Sep 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.